ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Madrigal Pharmaceuticals Inc

Madrigal Pharmaceuticals Inc (MDGL)

334,80
-3,49
(-1,03%)
Geschlossen 01 Februar 10:00PM
345,00
10,20
(3,05%)
Nach Börsenschluss: 1:59AM

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

Current Price
345,00
Gebot
345,00
Fragen
408,00
Volumen
260.468
334,02 Tagesbereich 347,20
168,2462 52-Wochen-Bereich 368,29
Marktkapitalisierung
Handelsende
338,285
Handelsbeginn
339,52
Letzte Trade
1
@
345.0001
Letzter Handelszeitpunkt
Finanzvolumen
US$ 88.767.252
VWAP
340,7991
Durchschnittliches Volumen (3 Mio.)
394.007
Ausgegebene Aktien
21.810.407
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-19,54
Gewinn pro Aktie (EPS)
-17,13
Erlöse
-
Nettogewinn
-373,63M

Über Madrigal Pharmaceuticals Inc

Madrigal Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular-metabolic diseases and non-alcoholic steatohepatitis (NASH). The product portfolio of the company includes MGL... Madrigal Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular-metabolic diseases and non-alcoholic steatohepatitis (NASH). The product portfolio of the company includes MGL-3196, an orally administered, small-molecule liver-directed B-selective THR agonist, which is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. Also, MGL-3196 reduces triglycerides in the plasma and liver by increasing fat metabolism and shows an anti-diabetic action. Mehr anzeigen

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
Madrigal Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker MDGL. The last closing price for Madrigal Pharmaceuticals was US$338,29. Over the last year, Madrigal Pharmaceuticals shares have traded in a share price range of US$ 168,2462 to US$ 368,29.

Madrigal Pharmaceuticals currently has 21.810.407 shares in issue. The market capitalisation of Madrigal Pharmaceuticals is US$7,38 billion. Madrigal Pharmaceuticals has a price to earnings ratio (PE ratio) of -19.54.

Option-Flow Madrigal Pharmaceuticals (MDGL)

Gesamtfluss

Bullisch

Nettoprämie

2M

Calls / Puts

350,00%

Käuf. / Verkä.

125,00%

OTM / ITM

28,57%

Sweeps

0,00%

MDGL Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
17.442.20405261287337.56345300408985324.90779054CS
425.127.85294485432319.88345266.44473501307.79916895CS
12-12-3.36134453782357357.02266.44394007312.9724459CS
2660.5821.2994866746284.42368.29200.63372462282.21885954CS
52122.5655.0980039561222.44368.29168.2462440985258.79515571CS
156285.8482.7702702759.2368.2954.3411380950210.73537565CS
260263320.73170731782368.2952.33289443186.82981422CS

MDGL - Frequently Asked Questions (FAQ)

What is the current Madrigal Pharmaceuticals share price?
The current share price of Madrigal Pharmaceuticals is US$ 345,00
How many Madrigal Pharmaceuticals shares are in issue?
Madrigal Pharmaceuticals has 21.810.407 shares in issue
What is the market cap of Madrigal Pharmaceuticals?
The market capitalisation of Madrigal Pharmaceuticals is USD 7,38B
What is the 1 year trading range for Madrigal Pharmaceuticals share price?
Madrigal Pharmaceuticals has traded in the range of US$ 168,2462 to US$ 368,29 during the past year
What is the PE ratio of Madrigal Pharmaceuticals?
The price to earnings ratio of Madrigal Pharmaceuticals is -19,54
What is the reporting currency for Madrigal Pharmaceuticals?
Madrigal Pharmaceuticals reports financial results in USD
What is the latest annual profit for Madrigal Pharmaceuticals?
The latest annual profit of Madrigal Pharmaceuticals is USD -373,63M
What is the registered address of Madrigal Pharmaceuticals?
The registered address for Madrigal Pharmaceuticals is 2711 CENTERVILLE ROAD, SUITE 400, WILMINGTON, DELAWARE, 19808
What is the Madrigal Pharmaceuticals website address?
The website address for Madrigal Pharmaceuticals is www.madrigalpharma.com
Which industry sector does Madrigal Pharmaceuticals operate in?
Madrigal Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
TCTMTCTM Kids IT Education Inc
US$ 0,764
(321,87%)
729,72M
REBNReborn Coffee Inc
US$ 3,31
(63,05%)
55,54M
FCUVFocus Universal Inc
US$ 5,87
(56,62%)
1,73M
SOPASociety Pass Inc
US$ 1,54
(56,50%)
13,82M
CYCNCyclerion Therapeutics Inc
US$ 3,92
(54,33%)
82,39M
ENVBEnveric Biosciences Inc
US$ 2,0899
(-46,41%)
1,57M
NIVFNewGenIvf Group Ltd
US$ 0,1489
(-42,51%)
14,8M
GLSTGlobal Star Acquisition Inc
US$ 8,83
(-39,10%)
23,89k
PRPHProPhase Labs Inc
US$ 0,2633
(-38,02%)
872,46k
SPGCSacks Parente Golf Inc
US$ 0,5601
(-37,86%)
7,27M
TCTMTCTM Kids IT Education Inc
US$ 0,764
(321,87%)
729,72M
NVDANVIDIA Corporation
US$ 120,07
(-3,67%)
388,54M
RIMEAlgorhythm Holdings Inc
US$ 0,02565
(5,12%)
338,75M
BHATBlue Hat Interactive Entertainment Technology
US$ 0,0355
(-11,25%)
236,29M
CLEUChina Liberal Education Holdings Ltd
US$ 0,1938
(30,77%)
234,8M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock